Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting

S. Baig, S. Qayyum, N. Saifullah, N. Ahmed (Karachi, Pakistan)

Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Session: Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Session type: Thematic Poster Session
Number: 2626
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Baig, S. Qayyum, N. Saifullah, N. Ahmed (Karachi, Pakistan). Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting. Eur Respir J 2014; 44: Suppl. 58, 2626

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005

Screening for tuberculosis by sputum culture among risk groups in a TB low- incidence country
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014


Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019


Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016

Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013



Sensitivity of Xpert MTB/RIF in induced sputum in smear negative pulmonary tuberculosis patients?
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017

Factors that predict for positive GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected tuberculosis
Source: International Congress 2014 – Paediatric bronchology
Year: 2014



MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India
Source: Eur Respir J 2014; 44: 1090-1093
Year: 2014